Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Inventory: 2019-2024

Historic Inventory for Legend Biotech (LEGN) over the last 6 years, with Dec 2024 value amounting to $23.9 million.

  • Legend Biotech's Inventory rose 23.93% to $29.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.2 million, marking a year-over-year increase of 23.93%. This contributed to the annual value of $23.9 million for FY2024, which is 23.00% up from last year.
  • Per Legend Biotech's latest filing, its Inventory stood at $23.9 million for FY2024, which was up 23.00% from $19.4 million recorded in FY2023.
  • In the past 5 years, Legend Biotech's Inventory ranged from a high of $23.9 million in FY2024 and a low of $1.7 million during FY2021.
  • For the 3-year period, Legend Biotech's Inventory averaged around $17.9 million, with its median value being $19.4 million (2023).
  • Its Inventory has fluctuated over the past 5 years, first dropped by 2.83% in 2021, then skyrocketed by 492.00% in 2022.
  • Yearly analysis of 5 years shows Legend Biotech's Inventory stood at $1.8 million in 2020, then fell by 2.83% to $1.7 million in 2021, then skyrocketed by 492.00% to $10.4 million in 2022, then surged by 87.69% to $19.4 million in 2023, then rose by 23.00% to $23.9 million in 2024.